Browse EX-10 agreements

Conexeu Sciences Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

---

CERTAIN IDENTIFIED INFOMRATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

CONEXEU SCIENCES BOARD MEMBER AGREEMENT

This Board Member Agreement ("Agreement") is made and entered into as of June 15, 2026 (the "Effective Date"), by and between Conexeu Sciences Inc., a Nevada corporation (the "Company") having offices at 50 West Liberty Street, Suite 880 Reno Nevada, USA 89501, and April Burke, located at [****] ("Board Member").

1. Appointment and Term

1.1 Appointment

The Company hereby appoints the Board Member to serve on its Board of Directors (the "Board") effective as of the Effective Date.

1.2 Term

The Board Member shall serve until the earlier of resignation, removal or the next annual meeting of stockholders.

2. Duties and Responsibilities

2.1 General Duties

…

Conexeu Sciences Inc.: Exhibit 10.4 - Filed by newsfilecorp.com

---

CONEXEU SCIENCES BOARD COMPENSATION NOTICE Effective June 15, 2026

Dear Dr. Lorenc,

On behalf of Conexeu Sciences, Inc., I am pleased to confirm the updated terms of your compensation as a member of the Board of Directors, effective June 15, 2026.

1.  Board Role

Name: Dr. Z. Paul Lorenc

Role: Non-Employee Director

Effective Date: June 15, 2026

 

2.  Committee Assignments

•  Compensation Committee: Member •  N&G Committee: Member

 

3.  Annual Compensation

Compensation Element

Annual Amount

Payment

Base Board Retainer

$50,000

Quarterly in arrears

Compensation Committee - Member

$6,000

Quarterly in arrears

N&G Committee - Member

$5,000

Quarterly in arrears

Annual RSU Grant

$100,000

Annually on June 15

TOTAL ANNUAL COMPENSATION

$161,000

 

Total Annual Compensation (cash + equity): $161,000

4.  Annual Equity Grant

…

Exhibit 10.1

 

uniQure N.V.

 

2014 Share Incentive Plan

 

(Amended and Restated Effective as of June 10, 2026)

 

1.             Purpose

 

The purpose of this 2014 Share Incentive Plan, as herein amended and restated (the “Plan”) of uniQure N.V., a public limited company incorporated under the laws of the Netherlands (the “Company”), is to advance the interests of the Company’s shareholders by enhancing the Company’s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests of such persons with those of the Company’s shareholders. Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the U.S. Internal Revenue Code of 1986, as amended, and any regulations thereunder (the “Code”) and any other business venture (including,

…

June 12, 2026

 

Park Ha Biological Technology Co., Ltd.

901, Building C

Phase 2, Wuxi International Life Science Innovation Campus

196 Jinghui East Road, Xinwu District

Wuxi, Jiangsu Province,

People’s Republic of China 214000

 

Dear Ms. Xiaoqiu Zhang:

 

This letter (the “Agreement”) constitutes the agreement between D. Boral Capital LLC (“D. Boral” or the “Placement Agent”) and Park Ha Biological Technology Co., Ltd., a Cayman Islands exempted company (the “Company”), pursuant to which the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of Class A ordinary shares (the “Shares” or “Securities”) of the Company, par value $0.001 per share (“Ordinary Shares”). The terms of the Placement shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Compa

…

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 12, 2026 between Park Ha Biological Technology Co., Ltd., a corporation existing under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below) as to the Shares (as defined below) and/or the Pre-Funded Warrants (as defined below) and the Warrant Shares (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

Document

Exhibit 10.1

Execution Version

SECOND AMENDMENT TO CREDIT AGREEMENT AND ACKNOWLEDGMENT

This SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of June 11, 2026 (this “Agreement”), to that certain Credit Agreement, dated as of November 14, 2025 (as amended by the First Amendment to Credit Agreement, dated as of March 9, 2026, and as the same may be further amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”, and as amended by this Agreement, the “Amended Credit Agreement”), by and among Waldencast PLC, a public limited company incorporated in Jersey (“Parent”), Milk Makeup LLC, a Delaware limited liability company (“Milk Makeup”), Obagi Cosmeceuticals LLC, a Delaware limited liability company (“Obagi Cosmeceuticals”, and collectively with Milk Makeup, the “Borrowers”, and each, a “Borrower”), the lenders party hereto (the “Lenders”) constituting Required Lenders under the Credit Agreement immediately prior to the date hereof, and LSSF II Offshore Investments, LP, an Ontario limited partnership acting by its gen

…

SHARE PURCHASE AGREEMENT

 

by and among

 

Zhang Shuge

 

and

 

Future Commercial Group Limited,

 

Future FinTech Group Inc.

 

Date: June 12, 2026

 

 

 

 

 

 

 

SHARE PURCHASE AGREEMENT

This Share Purchase Agreement (the "Agreement") is made, effective as of the 12th day of June, 2026, by and among Zhang Shuge, a PRC individual (the “Seller”), Future Commercial Group Limited, a company incorporated in the PRC (the “Buyer”), and Future FinTech Group Inc., a Florida corporation and publicly traded corporation (NASDAQ: FTFT) (the “Issuer” or “FTFT”). Future Commercial Group is a wholly-owned subsidiary controlled by Future FinTech Group Inc. The Seller, Buyer and FTFT are hereinafter collectively referred to as the “Parties” and each individually as a “Party”.

 

WHEREAS:

…

Document

Exhibit 10.1

CREDIT AGREEMENT

dated as of June 9, 2026

among

ACI ROVER PARENT, LLC as Borrower,

ACI ROVER, LLC

as a Subsidiary Guarantor,

THE OTHER SUBSIDIARY GUARANTORS PARTY HERETO FROM TIME TO TIME,

THE LENDERS PARTY HERETO FROM TIME TO TIME,

MORGAN STANLEY SENIOR FUNDING, INC. as Administrative Agent

and

MORGAN STANLEY SENIOR FUNDING, INC. as Collateral Agent

_______________________________________________________________

MORGAN STANLEY SENIOR FUNDING, INC., MUFG BANK, LTD. AND WELLS FARGO SECURITIES, LLC as Joint Lead Arrangers and Joint Bookrunners

---

TABLE OF CONTENTS

Section 1.01    Defined Terms    

Section 1.02    Terms Generally    

Section 1.03    Rates    

Section 1.04    Limited Condition Transactions; Pro Forma Calculations; Certain Other Matters.    

Section 1.05    Timing of Payment or Performance    

Section 1.06    Permitted Change of Control Transactions    

ARTICLE II THE CREDITS    

Section 2.01    Commitments.    

Section 2.02    Procedure for Borrowing.

…

Execution Version

 

SEVENTEENTH AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT

 

This SEVENTEENTH AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) dated as of June 12, 2026 is among: DIAMONDBACK ENERGY, INC., a Delaware corporation, as the Parent Guarantor (the “Parent Guarantor”), DIAMONDBACK E&P LLC, a Delaware limited liability company (the “Borrower”), each of the Lenders (as such term is defined in the Credit Agreement referred to below) party hereto and WELLS FARGO BANK, NATIONAL ASSOCIATION, as administrative agent for the Lenders (in such capacity, together with its successors in such capacity, the “Administrative Agent”).

 

R E C I T A L S

…

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE MAKER THAT SUCH REGISTRATION IS NOT REQUIRED.

PROMISSORY NOTE

February 2, 2026

 

$300,000

No. A-1

 

Osprey Acquisition Corp. III (the “Maker”) promises to pay to the order of Osprey Acquisition Sponsor III, LLC or its designee (collectively, the “Payee”) the principal sum of up to Three Hundred Thousand ($300,000) in lawful money of the United States of America, on the terms and conditions described below.

 

1.  Principal. The principal balance of this Note shall be repayable on earlier of (the “Maturity Date”) (a) the date on which Maker consummates its initial public offering (“IPO”) and (b) December 31, 2026.

 

2.  Interest. This Note shall bear no interest.

…

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2026, is made and entered into by and among Osprey Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), Osprey Acquisition Sponsor III, LLC, a Delaware limited liability company (the “Sponsor”), and Cantor Fitzgerald & Co., a New York general partnership (the “Representative”) (the Sponsor and the Representative together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

 

RECITALS

 

WHEREAS, the Company has 10,254,000 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”), issued and outstanding, up to 1,305,000 of which will be surrendered to the Company for no consideration depending on the extent to which the underwriters of the Company’s initial public offering exercise their over-allotment option;

…

INVESTMENT MANAGEMENT TRUST AGREEMENT

 

This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2026 by and between Osprey Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).

 

WHEREAS, the Company’s registration statement on Form S-1, (File No. 333-[●]) (the “Registration Statement”) and prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the “Units”), each of which consists of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Ordinary Share (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission;

…